Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab

Update Il y a 4 ans
Reference: NCT00532857

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the pathologic complete response rate to preoperative administration of Paclitaxel, Gemcitabine, and Trastuzumab (HerceptinÒ) (PGH)


Inclusion criteria

  • Breast Cancer

Links